Status:
COMPLETED
Detecting Sepsis in Patients With Severe Subarachnoideal Hemorrhage
Lead Sponsor:
Goethe University
Conditions:
Subarachnoid Hemorrhage
Subarachnoid Hemorrhage, Aneurysmal
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to evaluate the suitability of the SOFA score implemented by the Sepsis 3 guideline to detect sepsis in patients suffering from subrarachnoid hemorrhage.
Eligibility Criteria
Inclusion
- Critically ill patients suffering from moderate to severe subarachnoid hemorrhage (WFNS \>2).
Exclusion
- children under the age of 18 years Patients with minor subarachnoid hemorrhage \< WFNS stage 2.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT05246969
Start Date
June 1 2017
End Date
February 1 2022
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Niederrad, Hesse, Germany, 60590